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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThe concept of the ‘‘neurovascular unit,’’ emphasizing the interactions between neural and vascular components in the brain, raised the
notion that neural progenitor cell (NPC) transplantation therapy aimed at neural repair may be insufficient for the treatment of ischemic
stroke. Here, we demonstrate that enhanced neurovascular recovery via cotransplantation of NPCs and embryonic stem cell-derived
vascular progenitor cells (VPCs) in a rat strokemodel is correlated with improved functional recovery after stroke.We found that cotrans-
plantation promoted the survival, migration, differentiation, and maturation of neuronal and vascular cells derived from the cotrans-
planted progenitors. Furthermore, it triggered an increased generation of VEGF-, BDNF-, and IGF1-expressing neural cells derived
from the grafted NPCs. Consistently, compared with transplantation of NPCs alone, cotransplantation more effectively improved the
neurobehavioral deficits and attenuated the infarct volume. Thus, cotransplantation of NPCs and VPCs represents a more effective
therapeutic strategy for the treatment of stroke than transplantation of NPCs alone.INTRODUCTION
Stroke is the third leading cause of death and disability in
developed countries (van der Worp and van Gijn, 2007).
Although immediate interventionwith tissue plasminogen
activator (TPA) can provide some benefits during the acute
phase of stroke, no other clinically effective treatments are
currently available for this disease (van der Worp and van
Gijn, 2007). Stem cell transplantation represents a poten-
tial therapeutic strategy for stroke (Liu et al., 2014). Previ-
ous studies on stem cell transplantation emphasized the
replacement of either neural or vascular components in
the brain; however, the poor survival and differentiation
of both the transplanted cells and their progenies in the
hostile environment of the infarcted cortex hamper the ef-
ficacy of treatment (Martino and Pluchino, 2006; Kaneko
et al., 2012).
The ‘‘neurovascular unit’’ of the brain provides a concept
to consider improving the vasculature and other micro-
environmental components to alleviate severe neural cell
death that occurs after stroke, brain injury, and neurode-
generation, and comprises neurons, glia (astrocytes, micro-
glia, and oligodendroglia), and vascular cells (endothelia,
pericytes and vascular smooth muscle cells) (Zlokovic,
2010). The neurovascular signaling that can modulate
various degrees of neuronal plasticity may be critically
important for functional neurological recovery after CNSSteinjury (Moskowitz et al., 2010). Consequently, it has been
suggested that therapeutic approaches should target both
neural and vascular cell types in order to protect their struc-
tural and functional integrity and their reciprocal interac-
tions (Zlokovic, 2010; Moskowitz et al., 2010). In this
regard, Nakagomi et al., (2009) reported that in a mouse
stroke model, cotransplantation of endothelial cells (ECs)
together with neural stem/progenitor cells enhanced the
survival, proliferation, and differentiation of the neural
stem/progenitor cells andpartly improved cortical function
(locomotion under the light condition). However, whether
cotransplantation of neural progenitor cells (NPCs) with
vascular progenitor cells (VPCs) that produce multiple
vascular elements, including pericytes/smoothmuscle cells
(SMAs), would yield a more effective functional recovery
after focal ischemic injury in the cortex compared with
transplantation of NPCs alone has not been determined.
NPCs derived from embryonic day 14 (E14) mice have
been shown to differentiate into both neuronal and glial
cells (Reynolds andWeiss, 1996) in vitro.Mouse embryonic
stem cell-derived VPCs (ESC-VPCs) can differentiate into
not only ECs but also vascular mural cells (pericytes/
SMAs) (Yamashita et al., 2000), an important cell type
that is involved in construction of the blood-brain barrier
(Dalkara et al., 2011). In this study, we cotransplanted fetal
NPCs and ESC-VPCs in a rat model of transient middle
cerebral artery occlusion (tMCAO), a clinically relevantm Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authors 101
Figure 1. The Progenitor Cell Properties
of NPCs and ESC-VPCs Were Maintained
Prior to Transplantation
(A) Neurospheres derived from the telen-
cephalon of E14 GFP transgenic mice.
(B and C) Dissociated cells in the neuro-
spheres on a monolayer culture at 70% (B)
or 95% (C) density were immunostained
against the embryonic NPC marker NESTIN.
(D) Schematic diagram illustrating the pro-
cedure for deriving VPCs from ESCs.
(E) mRNA expression of specific marker
genes in undifferentiated ESCs, FLK1+, and
FLK1 cell fractions in day 4 EBs. VE-cad, VE-
cadherin. All RT-PCR experiments were per-
formed in triplicate.
(F–I) ESCs maintained in an undifferenti-
ated state (F) were forced to form EBs (G).
After the EBs were cultured in suspension for
4 days, the FLK1+ cell fraction was selected
via FACS, seeded on mitomycin-C-irradiated
fibroblasts, and exposed to VEGF. On day 11,
the culture was immunostained against the
EC-specific marker CD31. Bright-field (H)
and fluorescence (I) images are shown.
Scale bars, 100 mm.
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Brain Damage Repair by Neurovascular Progenitorsmodel of focal cerebral ischemia. In addition, we used
NPCs and VPCs of mouse origins in a rat stroke model to
mimic interspecies cell transplantation. We found that
cotransplantation of NPCs and VPCs facilitated the sur-
vival, differentiation, and/or maturation of neuronal and
vascular cells derived from the cotransplanted progenitors.
This beneficial effect of cotransplantation correlated with
greater improvements in motor function of the affected
limb and reduced infarct volume compared with NPC
transplantation alone, providing evidence that fostering
both neural and vascular recovery could be more effective
than neural repair alone in promoting functional recovery
from stroke-induced impairments.RESULTS
Characterization of NPCs and VPCs before
Transplantation
To generate NPCs that could be tracked after transplanta-
tion, we derived primary cells from the telencephalons of
E14 transgenic mice, which express a GFP reporter under
the control of a CMV promoter. A small proportion of the102 Stem Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authorsprimary cells generated neurospheres by day 8 of the initial
culture (Figure 1A). After collecting and expanding the cells
in theneurospheresonfibronectin-coatedplates for twopas-
sages,we characterized the cells via immunostaining against
NESTIN, a marker of embryonic NPCs. As shown in Figures
1B and 1C, more than 97% of the GFP+ cells expressed
NESTIN, suggesting that the majority of the cells in the cul-
ture maintained a progenitor cell phenotype. The neuro-
sphere cells that were expanded on the fibronectin-coated
plates at passage 2 were then used for transplantation.
We employed an embryoid body (EB) approach to derive
VPCs frommouse ESCs according to a previously described
method (Li and Stuhlmann, 2012). After 4 days of culture as
EBs, the fetal liver kinase 1 (FLK1)+ cell fractionwas selected
from the EBs via fluorescence-activated cell sorting (FACS;
Figure 1D), and an aliquot of the FLK1+ cells was subjected
to a panel of tests to evaluate the expression of various
markers via RT-PCR (Figure 1E). These tests revealed that
FLK1+ cells lost expression of the undifferentiated ESC
marker Oct4, expressed the hemangioblast markers Scl/
Tal1 and Flk1, and did not express the EC marker VE-cad-
herin. In contrast, the FLK1 cell fraction did not express
any of the above markers, and the ESCs only expressed
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derived from the day 4 EBs were hemangioblasts (Lugus
et al., 2009). To further elucidatewhether the FLK1+heman-
gioblasts were able to develop the vasculature in vitro, the
FLK1+ or FLK1 cells were placed on mitomycin-C treated
fibroblasts and exposed to VEGF (Figures 1F–1I). By day
11, the FLK1+ cells developedhighly branched vascular net-
works based on immunostaining against the EC marker
CD31 (Figures 1H and 1I). In sharp contrast, the FLK1 cells
did not form any vasculature under the same culture condi-
tions at the same time point. The FLK1+ hemangioblasts
were thus defined as VPCs and used for transplantation.
Cotransplantation of NPCs and VPCs Promoted Graft
Migration, Neural Graft Survival, Neuronal
Differentiation, and/or Maturation
To address whether cotransplantation of NPCs and
VPCs can promote graft migration, neural graft survival,
neuronal differentiation, and/or maturation, we injected
1 million NPCs and 0.5 million VPCs (25 ml/mice) into
the peri-infarct area of the injured rat brains (n = 6; Fig-
ure 2A). As controls, 1 million NPCs and 0.5 million
gamma-irradiated embryonic fibroblast cells (irrFCs; inac-
tive cells; 25 ml/mice) or 1 million NPCs alone (25 ml/mice)
were injected into the same site of injured brains (n = 6 for
each control group; Figure 2A). For lineage tracing, we used
the fluorescent vital dye Hoechst 33342 (Ho), which binds
DNA in live cells, to label VPCs and irrFCs prior to trans-
plantation in all the experiments.
By day 14, transplanted cells migrated from the peri-
infarct cortex into the infarct area in rats transplanted
with NPCs alone (Figures 2A and 2B), rats cotransplanted
with NPCs and irrFCs (Figure 2C), and rats cotrans-
planted with NPCs and VPCs (Figure 2D). To examine
whether cotransplantation of NPCs and VPCs affects the
migration of grafts, we measured the average vertical dis-
tance of the farthest migration. In the NPC and VPC
cotransplantation group, cells migrated 4.0-fold farther
than those in the NPC and irrFC cotransplantation group
(2,833.0 ± 763.8 mm versus 700.0 ± 150.0 mm; p < 0.01) or
5.7-fold farther than those in the NPC-alone transplanta-
tion group (2,833.0 ± 763.8 mm versus 500.0 ± 132.3 mm;
p < 0.01; Figure 2E).
To evaluate neural graft survival, we first performed a
TUNEL assay to detect dead GFP+ cells in the grafts. Less
than 0.01% of the GFP+ cells were TUNEL+ in all of the
groups examined on day 14 after transplantation (image
not shown). However, we found that the number of grafted
GFP+ cells out of the total number of injected GFP+ cells in
rats cotransplanted with NPCs and VPCs was significantly
higher than that in rats cotransplanted with NPCs and
irrFCs (2.5% versus 1.1%; p < 0.01) or rats transplanted
with NPCs alone (2.5% versus 1.0%; p < 0.01), suggest-Steing that cotransplantation of NPCs and VPCs promotes
neural graft survival (Figure 2F).
We then examined the differentiation ofGFP+ cells in the
infarct area via immunostaining against a panel of neural
markers, including NESTIN (a marker of neural stem cells),
doublecortin (DCX, a marker of neuronal precursors), glial
fibrillary acidic protein (GFAP, a marker of astroglial cells),
bIII-TUBULIN (a marker of neurons), and TAU1 (a marker
of mature neurons). We detected very few GFP+/NESTIN+
(<0.1%) or GFP+/DCX+ (<0.1%) cells in all of the three
groups on day 14 (data not shown). Surprisingly, themajor-
ity of the GFP+ cells expressed GFAP (Figures 2G–2K) and
only a small portion of the GFP+ cells expressed bIII-
TUBULIN (Figures 2L and 2M) in rats transplanted with
NPCs alone on day 14. A similar result was obtained for
rats cotransplanted with NPCs and irrFCs (Figure S1 avail-
able online).
In the rats cotransplanted with NPCs and VPCs, a large
number of GFP+ and Ho+ cells were detected in the infarct
cortex (Figures 3A and 3B). When we labeled the vessels us-
ing dye-conjugated LECTIN and immunostaining against
a-SMA, a marker of mural cells (Lopes et al., 2011), we
detected many mural cell-covered Ho+/LECTIN+ microves-
sels, some of which were surrounded by GFP+ cells in the
infarct area (Figure 3C). Immunostaining against neuronal
markers revealed a much higher percentage of GFP+/bIII-
TUBULIN+ neurons (70% versus 23%; p < 0.001) and a
lower percentage of GFP+/GFAP+ astroglial cells (30%
versus 76%; p < 0.001) in the rats cotransplanted with
NPCs and VPCs compared with those cotransplanted with
NPCs and irrFCs or those transplanted with NPCs alone
(Figure 3D).Additionally,whereasnoneof theGFP+ cells ex-
pressed the mature neuronal marker TAU1 in the two con-
trol groups (image not shown), an average of 12.3% ±
1.6%of theGFP+ cells expressed TAU1 in the group cotrans-
planted with NPCs and VPCs, suggesting much more
mature neuronal differentiation (Figure 3D).
To further examine whether the engrafted neurons
matured into specific neuronal subtypes, we stained the
brain sections againstg-aminobutyric acid (GABA), amarker
of GABAergic neurons, or glutamate vesicular transporter
(VGLUT1), a marker of glutamatergic neurons. None of the
GFP+ cells stained positively for VGLUT1 in any of the three
groups examined, andnoGFP+/GABA+cellsweredetected in
the two control groups. However, some GFP+ cells stained
positively for GABA in the lower middle part of the cortex
from the transplantation site (rectangular purple area in Fig-
ure 3A), which constituted 22.8% ± 3.6% of the engrafted
GFP+ cells in the rats cotransplanted with NPCs and VPCs
(Figure 3E). Next, we performed double immunostaining
against GABA and VGLUT1 to examine whether these
cells received synaptic inputs. Double immunostaining re-
vealed robust VGLUT1 staining onGFP+/GABA+ cell bodies,m Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authors 103
Figure 2. Cotransplantation of NPCs and VPCs Promoted Graft Migration and Neural Graft Survival
(A) Diagram illustrating the tour of cell migration in an injured brain. The infarct area is denoted in gray, the transplants are denoted in
green aggregates, the arrow indicates the direction of migration, and the vertical distance away from the edge of transplants is labeled.
(B–D) Low-magnification images of transplants in rat brains in the group transplanted with NPCs alone (B), the group cotransplanted with
NPCs and irrFCs (C), and the group cotransplanted with NPCs and VPCs (D) on day 14 after transplantation. Merged: merge of bright-field
and fluorescence images.
(E) The average vertical distance of the farthest migration in rats cotransplanted with NPCs and VPCs was compared with that in rats
cotransplanted with NPCs and irrFCs or rats transplanted with NPCs alone on day 14 after transplantation.
(F) The number of grafted GFP+ cells out of the total number of injected GFP+ cells in rats cotransplanted with NPCs and VPCs was compared
with that in rats cotransplanted with NPCs and irrFCs or rats transplanted with NPCs alone on day 14 after transplantation.
(G) Diagram illustrating the injection (black box) and migration (green boxes) sites of neural transplants in a rat brain. The infarct area is
denoted in gray.
(H) Low-magnification image of grafted GFP+ cells in a rat brain transplanted with NPCs alone on day 14 after transplantation.
(I) Enlarged image of the boxed region in (H).
(J and K) The GFP+ cells in the region marked by * in (I) were immunostained using antibodies against GFAP.
(L and M) The GFP+ cells in the region marked by ** in (I) were immunostained using antibodies against bIII-TUBULIN.
The data are presented as means ± SD (**p < 0.01; one-way ANOVA and Tukey’s post hoc). Scale bars, 2 mm in (B) and 100 mm otherwise.
See also Figure S1.
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matergic inputs (Figure 3E).
Cotransplantation of NPCs and VPCs Enhanced the
Vascular Graft Survival, Differentiation, Formation,
and Maturation of Microvessels
To determine whether cotransplantation of NPCs and
VPCs can promote vascular graft survival and the differ-104 Stem Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authorsentiation, formation, and maturation of blood vessels,
rats (n = 6) were transplanted with 0.5 million VPCs
alone (25 ml/mice) and compared with rats (n = 6) cotrans-
planted with 1 million NPCs and 0.5 million VPCs (25 ml/
mice). There were clusters of Ho+ cells in both the rats
transplanted with VPCs alone and the rats cotransplanted
with NPCs and VPCs on day 14 (Figures 4A and 4B).
TUNEL staining revealed that <0.01% of the Ho+ cells
Figure 3. Cotransplantation of NPCs and VPCs Promoted the Differentiation and/or Maturation of Neuronal Cells Derived from
Engrafted NPCs
(A) Left: diagram illustrating the injection (black box) and migration (orange box) sites of cotransplantation in a rat brain. The infarct area
is denoted in gray. Right: low-magnification image of grafted GFP+ and Ho+ cells in a rat brain cotransplanted with NPCs and VPCs on day 14
after transplantation.
(B) Top: enlarged view of the white-boxed region in (A). Bottom: enlarged view of the white-boxed region in the upper panel.
(C) Rat brains were perfused with LECTIN before dissection. The sections were then immunostained using antibodies against a-SMA. Left: a
representative image of a LECTIN+/a-SMA+ microvessel generated by the Ho+ cells in (B) (arrow). Right: a representative image of a
LECTIN+/a-SMA+ microvessel that is surrounded by GFP+ cells and was generated by the Ho+ cells in (B) (arrowhead). The x-z and y-z planes
of the three-dimensional view of merge images are shown on the right and below, respectively.
(D) Left: the GFP+ cells in (B) were immunostained using antibodies against GFAP, bIII-TUBULIN, or TAU1. Below is an enlarged view of the
arrow-highlighted cells in the upper panel. Right: the numbers of GFP+/GFAP+, GFP+/bIII-TUBULIN+, and GFP+/TAU1+ cells out of the total
number of grafted GFP+ cells in the infarct area in the group cotransplanted with NPCs and VPCs were compared with those in the group
cotransplanted with NPCs and irrFCs or the group transplanted with NPCs alone. bIII-TUB, bIII-TUBULIN.
(E) Left: the GFP+ cells in (B) were immunostained using antibodies against GABA or coimmunostained using antibodies against GABA and
VGLUT1. Insets show the enlarged view of the boxed region. Right: the numbers of GFP+/GABA+ or GFP+/VGLUT1+ cells out of the total
number of grafted GFP+ cells in the infarct area in the group cotransplanted with NPCs and VPCs were compared with those in the group
cotransplanted with NPCs and irrFCs or the group transplanted with NPCs alone.
The data are presented as means ± SD (***p < 0.001; Kruskal-Wallis test and Dunnett’s post hoc). Scale bars, 2 mm in (A), 100 mm in (B)
and (C), 20 mm in (D), and 40 mm in (E). See also Figure S1.
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shown). However, the number of grafted Ho+ cells out
of the total number of injected Ho+ cells was 2-fold
higher in rats cotransplanted with NPCs and VPCs than
in those transplanted with VPCs alone (38.2% versus
17.3%; p < 0.01; Figure 4C), suggesting that cotransplan-Stetation of NPCs and VPCs enhanced the vascular graft
survival.
To compare the vascular differentiation capacity of
grafted VPCs, we used LECTIN to label the vessels and
quantified the number of Ho+ nuclei within the LECTIN-
perfused vessels out of the grafted Ho+ nuclei (Figure 4D).m Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authors 105
Figure 4. Cotransplantation of NPCs and
VPCs Promoted Vascular Graft Survival
and the Differentiation, Formation, and
Maturation of Microvessels
(A and B) Low-magnification image of
transplanted Ho+ cells in rat brains in the
group transplanted with VPCs alone (A) or
the group cotransplanted with NPCs and
VPCs (B) on day 14 after transplantation.
Merge: merge of bright-field images with
fluorescence images.
(C) The number of grafted Ho+ cells out of
the total number of injected Ho+ cells in the
group cotransplanted with NPCs and VPCs
was compared with that in the group
transplanted with VPCs alone on day 14 after
transplantation.
(D) Representative image of LECTIN-
perfused vessels derived from the Ho+ VPCs.
(E) The number of Ho+ nuclei within the
LECTIN-perfused vessels relative to the
number of grafted Ho+ nuclei in the group
cotransplanted with NPCs and VPCs was
compared with that in the group trans-
planted with VPCs alone on day 14 after
transplantation.
(F and G) High-magnification images of
the Ho+/LECTIN+ or Ho+/LECTIN+/a-SMA+
microvessels in (D).
(H and I) Magnified images of the arrow-
marked microvessels in (F) and (G). The x-z
andy-zplanesof three-dimensional views are
shown on the right and below, respectively.
(J) The numbers of Ho+/LECTIN+ or Ho+/
LECTIN+/a-SMA+ microvessels in the infarct
area in the group cotransplanted with NPCs
and VPCs were compared with those in the
group transplanted with VPCs alone on day
14 after transplantation.
The data are presented as means ± SD (**p <
0.01, ***p < 0.001; Kruskal-Wallis test and
Dunnett’s post hoc). Scale bars, 2 mm in (B),
200 mm in (D), and 50 mm otherwise.
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plantedwithNPCs andVPCswas7.5-fold (30.7%versus
4.1%; p < 0.001) greater than in the rats transplanted
with VPCs alone (Figure 4E), suggesting a significant
improvement in the vascular differentiation capacity of
grafted VPCs.
To determine whether cotransplantation of NPCs and
VPCs can promote the formation of functional vessels
derived from grafted VPCs, we counted the Ho+/LECTIN+
microvessels (Figures 4F and 4G) or mural cell-covered
Ho+/LECTIN+ microvessels (Figures 4H and 4I) in the
infarct area in both groups. We found 5.4-fold more106 Stem Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The AuthorsHo+/LECTIN+ microvessels in the infarct area of rats co-
transplanted with NPCs and VPCs compared with those
transplanted with VPCs alone (17,287.0 ± 3,286.0 versus
3,198.0 ± 1,410.0, respectively; p < 0.001; Figure 4J).
Similarly, immunostaining against a-SMA revealed that
the number of Ho+/LECTIN+/a-SMA+ microvessels in the
infarct area of rats cotransplanted with NPCs and VPCs
was 10.8-fold greater (5,031.0 ± 909.6 versus 466.0 ±
355.0; p < 0.001; Figure 4J) than in rats transplanted with
VPCs alone. It should be noted that we did not detect
LECTIN+ microvessels derived from the host in the infarct
area in any of the groups examined.
Figure 5. Cotransplantation of NPCs and
VPCs More Effectively Improved the Neu-
robehavioral Deficits
(A) Diagram illustrating the experimental
procedures used to evaluate neural behav-
ioral performance and infarct volume
changes in rats after various treatments.
Sites of injection shown in sagittal planes
and coronal planes are depicted on the left
and right. OB, olfactory bulb; Ctx, cortex;
LV, lateral ventricle; Hp, hippocampus. The
infarct area is denoted in gray.
(B–D) The average rotarod performance (B),
right-biased swing % (C), and mNSS (D) of
rats in the group cotransplanted with NPCs
and VPCs were compared with those in the
group cotransplanted with NPCs and irrFCs,
the group transplantedwith irrFCs alone, and
thegroup sham injectedwith PBSprior to cell
transplantation (pre) and on days 3, 7, and
14 after cell transplantation (n = 18 for each
group). The data are presented asmeans± SD
( *p < 0.05; **p < 0.01; ***p < 0.001; B, one-
way ANOVA and Tukey’s post hoc; C and D,
Kruskal-Wallis test and Dunnett’s post hoc).
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Improves Functional Neurological Deficits
To determine whether cotransplantation of NPCs and
VPCs can promote functional recovery more effectively
than transplantation of NPCs alone, we examined neuro-
behavioral parameters using the accelerating rotarod test,
elevated body swing test (EBST), andmodified neurological
severity score (mNSS) test. For these tests, rats (n = 18) co-
transplanted with 1 million NPCs and 0.5 million VPCs
(25 ml/mice) were compared with rats (n = 18) transplanted
with 1 million NPCs and 0.5 million irrFCs (25 ml/mice),
rats (n = 18) transplanted with 1.5 million irrFCs alone
(25 ml/mice), or rats (n = 18) sham injected with PBS
(25 ml/mice; Figure 5A). The accelerating rotarod test pro-
vides an index of forelimb and hindlimb motor coordina-
tion and balance (Hamm et al., 1994). The rats displayed
a significantly shorter duration of remaining on the accel-
erating rotarod on day 1 after stroke compared with before
the stroke (17.4 ± 7.4 s versus 145.6 ± 29.0 s; p < 0.001; Fig-
ure 5B). On day 7, although the duration of remaining on
the rotarod was significantly longer in rats cotransplanted
with NPCs and irrFCs (59.1 ± 17.6 s) than in rats trans-
planted with irrFCs alone (35.2 ± 6.6 s; p < 0.01) or rats
sham injected with PBS (31.6 ± 6.9 s; p < 0.001; Figure 5B),
cotransplantation of NPCs and VPCs prolonged the dura-
tion of remaining on the rotarod more effectively than co-
transplantation of NPCs and irrFCs at this time point
(79.2 ± 13.2 s; p < 0.05; Figure 5B). On day 14, the rats
cotransplanted with NPCs and VPCs still exhibited aStesignificantly longer duration of remaining on the rotarod
(105.5 ± 16.2 s) compared with rats cotransplanted with
NPCs and irrFCs (70.2 ± 19.7 s; p < 0.01), transplanted
with irrFCs alone (45.2 ± 7.4 s; p < 0.001), or sham injected
with PBS (51.6 ± 9.4 s; p < 0.001; Figure 5B). In contrast, no
difference was observed among the other three groups at
this time point (Figure 5B).
In addition to the rotarod test, we performed the EBST
to evaluate asymmetrical motor behavior (Borlongan and
Sanberg, 1995). The rats exhibited a 100% tendency to
turn toward the right side (contralateral to the lesion) on
day 1 after stroke (Figure 5C). No difference was detected
among the groups during the first 7 days (Figure 5C). On
day 14, the percentage of right-biased swinging in rats co-
transplanted with NPCs and VPCs (35.0% ± 15.7%) was
significantly lower than that in rats cotransplanted with
NPCs and irrFCs (69.2% ± 20.6%; p < 0.01), transplanted
with irrFCs alone (84.0% ± 11.4%; p < 0.001), or sham in-
jected with PBS (88.8% ± 16.4%; p < 0.001; Figure 5C). In
contrast, no difference was observed among the other three
groups at this time point (Figure 5C).
Finally, we used themNSS test (14 points) to evaluate the
motor abilities, reflexes, and balance of the rats (Boltze
et al., 2006). On day 1 after stroke, all of the rats displayed
a high mNSS (9.2 ± 1.0). On day 7, the rats cotransplanted
with NPCs and VPCs displayed a significantly lower mNSS
(3.2 ± 1.0) than the rats cotransplanted with NPCs
and irrFCs (5.6 ± 1.3; p < 0.01), transplanted with irrFCs
alone (6.8 ± 0.8; p < 0.001), or sham injected with PBSm Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authors 107
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tion of NPCs and VPCs further reduced the mNSS. The
mNSS of rats cotransplanted with NPCs and VPCs (1.0 ±
0.9) was significantly lower than that of rats cotransplanted
with NPCs and irrFCs (3.9 ± 1.7; p < 0.05), trans-
planted with irrFCs alone (5.6 ± 1.1; p < 0.01), or sham in-
jectedwith PBS (6.8 ± 2.3; p < 0.001; Figure 5D). In contrast,
no difference was observed among the other three groups
throughout the 14-day period (Figure 5D).
Cotransplantation of NPCs and VPCs More Effectively
Attenuates the Infarct Volume
It was previously reported that T2-weighted MRI hyperin-
tensity reflects vasogenic edema and cortical infarction,
which constitute the total infarct volume during subacute
stages from 24 hr to 2 weeks after stroke (Schiemanck
et al., 2005). To assess whether cotransplantation of NPCs
and VPCs could be more effective for attenuating infarct
volume than transplantation of NPCs alone from day 1
to day 14 after stroke, we used T2-weighted MRI to detect
the infarct volume in groups in which we had examined
neurobehavioral parameters. Based on the T2 hyperinten-
sity, the infarct volume was between 44% and 45% of the
contralateral brain for all of the rats on day 1 after stroke
(Figure 6A). After transplantation, the infarct volume (per-
centage of the contralateral hemisphere) of the rats co-
transplanted with NPCs and VPCs (31.5% ± 2.5%) was
significantly smaller than that of rats either transplanted
with irrFCs alone (41.8% ± 5.9%; p < 0.05) or sham injected
with PBS (40.9% ± 5.2%; p < 0.01) on day 7 (Figure 6B). No
difference was detected between the rats cotransplanted
with NPCs and VPCs and the rats cotransplanted with
NPCs and irrFCs at this time point (Figure 6B). By day 14,
the infarct volume of the rats cotransplanted with NPCs
and VPCs (23.7% ± 1.2%) was significantly smaller than
that of rats cotransplanted with NPCs and irrFCs
(32.5% ± 5.2%; p < 0.05), transplanted with irrFCs alone
(35.1% ± 5.4%; p < 0.05), or sham injected with PBS
(36.9% ± 3.8%; p < 0.001; Figure 6B). In contrast, no differ-
ence was observed among the other three groups at this
time point (Figure 6B).
Cotransplantation of NPCs and VPCs Promotes
Engrafted Neural Cells Expressing VEGF, BDNF,
and IGF1
To determine the molecular basis underlying the beneficial
effect of cotransplantation of NPCs and VPCs, we exam-
ined the expression of a set of growth/trophic factors,
including brain-derived neurotrophic factor (BDNF),
vascular endothelial growth factor (VEGF), insulin growth
factor 1 (IGF1), and nerve growth factor (NGF), by double
immunostaining against cell-type-specific markers and
growth/trophic proteins in all of the experimental groups.108 Stem Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The AuthorsThe immunostaining revealed that BDNF was expressed
by a subset of the grafted GFP+/NESTIN+ NPCs (Figure 7A).
BDNF was also synthesized by some GFP+/GFAP+ astroglia
(Figure 7B). Aside from BDNF, many GFP+/GFAP+ cells
expressed VEGF (Figure 7C). Notably, a subset of grafted
GFP+/bIII-TUBULIN+ neurons expressed IGF1 (Figure 7D).
No detectable immunostaining against NGF was found
in the infarct area. In addition, none of the Ho+ vascular
cells expressed any of the aforementioned growth/trophic
factors in the rats cotransplanted with NPCs and VPCs or
transplanted with VPCs alone. It should be noted that
we did not detect growth/trophic factor-expressing cells
derived from the host in the infarct area in any of the
groups examined.
To assess whether cotransplantation of NPCs and VPCs
could promote the neural production of growth/trophic
factors, we counted the number of GFP+/NESTIN+/BDNF+,
GFP+/GFAP+/BDNF+, GFP+/GFAP+/VEGF+, and GFP+/bIII-
TUBULIN+/IGF1+ cells in the infarct area in the group co-
transplanted with NPCs and VPCs compared with either
the group cotransplanted with NPCs and irrFCs or the
group transplanted with NPCs alone on days 7 and 14.
No difference in the numbers of growth/trophic factor
expressing cells was observed between the control groups
on either day 7 or 14 (Figure 7E). On day 7, the number
of GFP+/NESTIN+/BDNF+ cells in the group cotransplanted
with NPCs and VPCs (696.6 ± 120.0) was 2-fold greater
than that in either the group transplanted with NPCs and
irrFCs (325.0 ± 29.1; p < 0.01) or the group transplanted
with NPCs alone (345.6 ± 40.11; p < 0.05; Figure 7E). No
GFP+/NESTIN+/BDNF+ cells were detected in any of the
three groups on day 14, likely due to the full differentiation
of GFP+/NESTIN+ cells (Figure 7E). Cotransplantation of
NPCs and VPCs also promoted the production of BDNF
in astroglia. The number of GFP+/GFAP+/BDNF+ cells in
the group cotransplanted with NPCs and VPCs (1,294.0 ±
136.2) was2.4-fold greater than that in the group cotrans-
planted with NPCs and irrFCs (5,31.3 ± 74.0; p < 0.01) or
the group transplanted with NPCs alone (537.3 ± 65.9;
p < 0.01) on day 7 (Figure 7E). By day 14, the group cotrans-
planted with NPCs and VPCs still displayed 2-fold
more GFP+/GFAP+/BDNF+ cells (5,328.0 ± 201.3) than
either the group cotransplanted with NPCs and irrFCs
(2,606.0 ± 405.9; p < 0.01) or the group transplanted with
NPCs alone (2,565.0 ± 1133.0; p < 0.01; Figure 7E). Simi-
larly, the production of VEGF in astroglia was also
enhanced after cotransplantation of NPCs and VPCs. The
number of GFP+/GFAP+/VEGF+ cells in the group cotrans-
planted with NPCs and VPCs (2,481.0 ± 366.6) was 2.5-
fold greater than that in the group cotransplanted with
NPCs and irrFCs (995.7 ± 152.5; p < 0.01) and 2.4-fold
greater than that in the group transplanted with NPCs
alone (1,026.0 ± 196.4; p < 0.01) on day 7. In contrast, no
Figure 6. Cotransplantation of NPCs and
VPCs More Effectively Attenuated the
Cortical Infarct Volume
(A) Images captured via MRI of the same
rats in each group prior to cell trans-
plantation (pre) and on days 7 and 14 after
cell transplantation.
(B) The average infarct volumes of rats
evaluated by MRI in group cotransplanted
with NPCs and VPCs were compared with
those in the group cotransplanted with NPCs
and irrFCs, the group transplanted with
irrFCs alone, and the group sham injected
with PBS on day 1 before cell trans-
plantation and days 7 and 14 after cell
transplantation (n = 18 for each group). The
data are presented as means ± SD (*p<0.05;
**p < 0.01; ***p < 0.001; Kruskal-Wallis
test and Dunnett’s post hoc).
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ure 7E). Finally, the number of GFP+/bIII-TUBULIN+/IGF1+
cells in the group cotransplanted with NPCs and VPCs
(1,460 ± 449.7) was5.3-fold greater than that in the group
cotransplanted with NPCs and irrFCs (274.3 ± 17.6; p <
0.01) and 5.0-fold greater than that in the group trans-Steplanted with NPCs alone (292.5 ± 34.5; p < 0.01) on
day 7 (Figure 7E). By day 14, the number of GFP+/bIII-
TUBULIN+/IGF1+ cells in the group cotransplanted with
NPCs and VPCs (2,277.0 ± 262.4) was 6.8-fold greater
than that in the group cotransplanted with NPCs and
irrFCs (335.9 ± 116.1; p < 0.001) and 5.0-fold greaterm Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authors 109
Figure 7. Cotransplantation of NPCs and VPCs Enhanced the Differentiation of VEGF-, BDNF-, and IGF1-Producing Neural Cells
Derived from Transplanted NPCs
(A–D) Representative images of GFP+/NESTIN+/BDNF+, GFP+/GFAP+/BDNF+, GFP+/GFAP+/VEGF+, and GFP+/bIII-TUBULIN+/IGF1+ cells
(arrow).
(E) The average total numbers of GFP+/NESTIN+/BDNF+, GFP+/GFAP+/BDNF+, GFP+/GFAP+/VEGF+, and GFP+/bIII-TUBULIN+/IGF1+ cells in
the group cotransplanted with NPCs and VPCs were compared with those in the group cotransplanted with NPCs and irrFCs or the group
transplanted with NPCs alone (n = 6 for each group) on day 7 or 14 after transplantation.
(F) Proposed model by which cotransplantation of NPCs and VPCs promotes neurovascular regeneration, infarct volume reduction, and
recovery from functional neurological deficits. The data are presented as means ± SD (*p < 0.05; **p < 0.01; ***p < 0.001; Kruskal-Wallis
test and Dunnett’s post hoc). Scale bars, 20 mm.
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(463.1 ± 106.7; p < 0.001; Figure 7E).DISCUSSION
Numerous previous studies have described the transplanta-
tion of NPCs alone or ECs alone for the treatment of
ischemic stroke (Liu et al., 2014). A recent study also
demonstrated an enhanced functional recovery after co-
transplantation of neural stem/progenitor cells and ECs
(Nakagomi et al., 2009). However, in the present study,
we cotransplanted ESC-VPCs with NPCs to treat ischemic
stroke, which produced not only neural cells but also ECs
and pericytes/SMAs, thus providing nearly all important
components for recovery of the neurovascular unit. These
beneficial outcomes appear to be due to themutual support110 Stem Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authorsprovided by each progenitor cell type and the enhanced
expression of growth/trophic factors by grafted neural
cells, which allow the cotransplanted progenitor cells to
generate both the neural and vascular cell types that consti-
tute the cerebral parenchyma (Figure 7F).
Rehabilitation after brain ischemia requires the recovery
of both neural and vascular components in the damaged
brain area. In this study, the cotransplanted NPCs and
VPCs differentiated into neurons, astroglia, ECs, andmural
cells in the infarct area. The latter two developed into
microvessels or mural cell-covered microvessels. It was pre-
viously reported that endogenous neovascularization is
poor in the infarct area after stroke in rats (Navaratna
et al., 2009); however, we showed that the regeneration
of microvessels derived from the transplanted VPCs was
effective. These microvessels promoted the survival, differ-
entiation, and maturation of neuronal cells derived from
Stem Cell Reports
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NPCs generated neurons (bIII-TUBULIN+). Approximately
17% of these neurons were mature neurons (TAU1+) and
32% were GABAergic neurons that displayed the ability
to receive glutamatergic synaptic inputs, whichmay under-
lie the more effective improvement in motor coordination
and balance of the rats based on the results of the rotarod,
EBST, and mNSS tests during the 14 days after cotransplan-
tation of NPCs and VPCs. Due to the lack of vascular
supply, implanted NPCs display poor survival and differen-
tiation into neuronal cells, ultimately risking graft failure in
the group transplanted with NPCs alone or the group co-
transplanted with NPCs and irrFCs. Supporting data for
graft failure were generated in a preliminary long-term
study of transplanted GFP+ NPCs in the ischemic rat brain,
inwhich noGFP+ cells were detected on day 28 after stroke,
whereas successfully engrafted and properly differentiated
GFP+ neural cells were detected upon cotransplantation
of NPCs andVPCs at the same time point (data not shown).
Consistent with these results, cotransplantation of NPCs
and irrFCs did not improve some of the neurological pa-
rameters on day 7 and completely failed to display efficacy
in neurobehavioral improvement on day 14. Reestab-
lishing the vascular network in the infarct area appears to
have a neuroprotective effect on neural transplants, and
thus its importance for successful NPC transplantation
therapy cannot be underestimated.
Stroke causes damage to not only a core area of the brain
but also the peri-infarct area surrounding the ischemic core
after the initial ischemic insult, which leads to enlargement
of the infarct volume and, ultimately, irreversible tissue loss
(Jung et al., 2013). This study demonstrates that cotrans-
plantation of NPCs and VPCs prevents the progression of
brain atrophy more effectively than cotransplantation of
NPCs and irrFCs (27% greater reduction in infarct vol-
ume). Post hoc immunohistochemical analysis revealed
that cotransplantation of NPCs and VPCs induced the gen-
eration of more neurotrophic or angiogenic factor-produc-
ing neural cells than transplantation of NPCs, suggesting
that cotransplantation of NPCs and VPCs has the potential
to mediate a greater neuroprotective effect when these fac-
tors are delivered to both the infarct and peri-infarct cortex.
In addition, the formation of mature microvessels in the
infarct area by cotransplanted progenitor cells could exert
a beneficial effect by increasing the blood flow, facilitating
growth/trophic factor delivery. Thus, cotransplantation of
NPCs and VPCs may provide mutually supportive trophic
mechanisms of neural protection via production of VEGF,
BDNF, and IGF1 in the microenvironment that preserve
the host brain from further degeneration.
The expressionof neurotrophic or angiogenic proteins by
grafted neural cells benefits the two types of transplanted
progenitors in the infarct core. First, BDNF, which is knownSteto be neuroprotective (Louhivuori et al., 2011), may ensure
the survival of newly formed neurons during the first week
after transplantation. Second,VEGF, oneof themost impor-
tant angiogenic factors (Horie et al., 2011), and IGF1,
considered as both neurotrophic and angiogenic (Zhu
et al., 2009), may improve the neovascularization of trans-
plantedVPCs throughout the 14days after transplantation.
Third, during the second week after transplantation, the
strong expression of BDNF by newly engrafted astroglial
cells may not only mediate consistent neuroprotection
but also play a role in the control of the excitatory/inhibi-
tory balance by regulating local GABAergic circuits (Jiao
et al., 2011). The latter is important for proper neural
network formation between the grafted and host neurons.
There are some limitations in the present study. First,
we used Ho dye for in vivo tracking of grafted ESC-VPCs
because these cells only undergo a relatively limited round
of cell divisions before terminal differentiation occurs
(Yamashita et al., 2000). The use of Ho dye to trace progen-
itor cells is similar to what was described in a previous study
(Goodell et al., 1996). It shouldbepointedout thatHodye is
not an optimal tracer for lineage tracing because it becomes
diluted alongwith cell divisions,whichmay result in an un-
derestimationof thenumberof labeled cells at theendpoint.
In addition, the debris of the dying Ho dye-labeled cells can
be takenupbymicrophages, leading to false-positive results.
Moreover, although theconcentrationofHodyeweused for
cell labeling does not cause apparent cell death (<0.01%), as
evaluated by cytotoxicity tests for 3 consecutive days after
the initial plating, higher concentrations of the dye can be
toxic to cells and should be used with caution. Second, the
majority of grafted fetal NPCs developed into GABAergic
neuronal subtypes, and no glutamatergic neurons were
generated. The lack of replacement for glutamatergic neu-
rons might decrease glutamate production and conse-
quently the glutamate pool in the infarct area, whichwould
probably limit the extent of the restoration. Third, consis-
tent with previous work by Nakagomi et al. (2009), this
study reinforces the notion that cotransplantation of
NPCs and ESC-VPCs for neurovascular regeneration is a bet-
ter therapeutic strategy for the treatment of ischemic stroke
than transplantation ofNPCs alone.However, for therapeu-
tic applications, it is desirable to deriveNPCs andVPCs from
the same donor, e.g., to derive these progenitors from the
same pluripotent stem cells. Further studies could address
whether using ESC-derived NPCs for cotransplantation
would provide the same benefits as fetal NPCs.EXPERIMENTAL PROCEDURES
Cell Culture
NPCs were isolated from the telencephalon of E14 GFP transgenic
mice (Research Center of Nanjing University, Nanjing, China) asm Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authors 111
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Experimental Procedures. To derive the VPCs, murine R1 ESCs
(Institute of Biochemistry and Cell Biology, Shanghai, China)
were cultured on mitomycin-C-treated feeder cells in ESC growth
medium. Details regarding themethods used for ESCmaintenance
and differentiation can be found in Supplemental Experimental
Procedures. The FLK1+ cell fraction from day 4 EBs was isolated
using a flow cytometer (Beckman-Coulter). The FLK1+ cells were
either immediately used for cell transplantation or seeded on fibro-
blasts treated withmitomycin-C (Sigma), and exposed to 50 ng/ml
VEGF (R&D Systems) for in vitro experiments.
tMCAO
To induce focal cerebral ischemia, adultmale rats (Sprague-Dawley,
3 months old, 250–300 g; Shanghai Laboratory Animal Center,
Shanghai, China) were subjected to tMCAO for 2 hr. MRI was
performed 24 hr after tMCAO. Only rats that displayed an infarct
volume between 41% and 44% of the contralateral hemisphere
were used for all of the experiments in the study. Animal surgeries
were performed as previously described (Yang and Betz 1994) and
in Supplemental Experimental Procedures. All animal procedures
were approved by the Shanghai Jiaotong University Administra-
tive Panel on Laboratory Animal Care.
Cell Transplantation
Cells were transplanted into the peri-infarct area at 24 hr after
ischemic stroke in rats. To track VPCs and irrFCs after transplanta-
tion, the VPCs or irrFCs were incubated in Hoechst 33342 (Sigma-
Aldrich) medium (7.5 mg/ml) for 5 min at 37C. The rats were
treated with 25 ml of the cell suspension at the densities indicated
in Results or with PBS along the anterior-posterior axis in the cor-
tex at the coordinates described in Supplemental Experimental
Procedures. The rats were injected i.p. daily with cyclosporine A
(CsA, 10 mg/kg; Sigma-Aldrich) for immunosuppression from
day 1 to day 14 after cell transplantation. On day 7 or day 14,
the rats were transcardially perfused with heparinized saline
(0.9%) and fixed with 4% paraformaldehyde (PFA). Five equidis-
tant sets of coronal sections (20 mm thick) were generated using a
cryostat and stored in cryoprotectant solution at 80C until use.
Cell Migration
Fourteen days after transplantation, transplants were visualized by
fluorescencemicroscopy. Themigration of transplanted cells in rat
brain slices was quantified in terms of the maximum distance. For
each transplant, cells that had migrated the farthest from the edge
of the transplants were measured. In each rat, the average from
three coronal slices was obtained. The average of vertical distance
of the farthest migration frommultiple transplants is presented in
Figure 2E. Six brains were analyzed for each group.
MRI
All MRI experiments were performed using a 3T General Electric
MR system (GE Medical Systems). The brains were examined via
T2-weighted MRI using the imaging parameters described in
Supplemental Experimental Procedures. Subsequentmeasurement
processing was performed using ImageJ and MRI Cell Image
Analyzer (Montpellier RIO Imaging Volker Baecker) software. The112 Stem Cell Reports j Vol. 3 j 101–114 j July 8, 2014 j ª2014 The Authorsinfarct volume was calculated based on the following formula:
(volume in the contralateral hemisphere  noninfarct volume in
the ipsilateral hemisphere) / volume in the contralateral hemi-
sphere 3 100%.
In Vivo LECTIN-DyLight 594 Angiography
LECTIN-DyLight 594 (Vector Laboratories) was administered to
anesthetized rats via the femoral vein 5min before they were sacri-
ficed on day 14. The rats were then transcardially perfusedwith ice-
cold heparinized PBS and their brains were isolated and embedded
in Tissue-Tek O.C.T. compound (Sakura Finetek).
Neurobehavioral Tests
All neurobehavioral tests were performed by an investigator who
was blinded to the experimental groups. The rats were trained for
3 consecutive days prior to surgery. Neurobehavioral tests were per-
formed before stroke occurred and on days 1, 3, 7, and 14 after the
stroke. Details regarding the methods used for the rotarod, EBST,
and mNSS tests can be found in Supplemental Experimental
Procedures.
Immunofluorescence Staining
Brain sections were fixed and stained with the appropriate anti-
bodies. Details regarding the immunostaining procedures and pri-
mary antibodies used for immunofluorescence can be found in
Supplemental Experimental Procedures. The primary antibodies
were detected using the appropriate secondary antibodies conju-
gated to Alexa Fluor 488, 594, or 633 (Jackson ImmunoResearch).
Images were viewed under a laser-scanning confocal microscope
(TCS SP5II; STED CW; Leica). Serial images were captured along
the z axis every 1 mm to a depth of 20 mm.
Cell Counting
Brainswere sectionedat20mmintervals fromapproximately+1mm
and5mmtobregma. Everyninth sectionof the serial sectionswas
collected, placed on the slide, and processed/counted forGFP+ cells,
Ho+ cells, or LECTIN-perfused vessels, or stained with antibodies
against the cell-type-specific markers or growth/trophic proteins.
Images were captured using a laser-scanning confocal microscope.
To estimate the total cell number in a whole brain, we counted the
total numbers of cells or positively stained cells in one set of serial
sections (containing every ninth section) and then multiplied
them by nine.
RNA Extraction and RT-PCR
Total RNA was isolated from undifferentiated ESCs and FLK1+
and FLK1 cell fractions from day 4 EBs using Trizol (Invitrogen).
The RNA was treated with DNase I (Invitrogen) to eliminate any
contaminating DNA. RT-PCRs were performed using SuperScript
III (Invitrogen) according to the manufacturer’s instructions. The
primer sequences used for this study can be found in Supplemental
Experimental Procedures.
Statistical Analysis
The results are presented as the means ± SD and were analyzed via
the unpaired t test, the Kruskal-Wallis test, or one-way ANOVA.
Stem Cell Reports
Brain Damage Repair by Neurovascular ProgenitorsPost hoc comparisonswere conducted using either Tukey’s or Dun-
nett’s test. Statistical analysis was performed using PRISM software
(GraphPad).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and one figure and can be foundwith this article online
at http://dx.doi.org/10.1016/j.stemcr.2014.05.012.
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